A real-world study in Bangladesh has shown that the Oxford University/AstraZeneca vaccine against the coronavirus has produced antibodies in 97 per cent of the recipients.
Experts, however, still emphasise continuing practices like physical distancing and wearing facemasks as there is no confirmed data on how long the antibodies will last and provide protection against COVID-19, reports bdnews24.com.
The government’s Institute of Epidemiology, Disease Control and Research or IEDCR published the results of the study on Wednesday, saying that 92 per cent of the recipients produced antibodies a month after being injected with the vaccine.
The number of recipients with antibodies rose to 97 per cent two months after the jabs, the study showed.
Participants of the study who were infected with the coronavirus developed four times as much antibodies than the others.